VCCC Research and Education Lead, Professor David Wiesenfeld will host seminar 3 of this 3-part webinar series, aimed to equip participants with the knowledge to manage ethically complex situations and decisions in head and neck cancer treatment.
In the final seminar, we examine ‘the ethics of progress’ in head and neck cancer treatment, including immunotherapy, robotic treatments and experimental and expensive therapies.
A panel of multidisciplinary experts will respond to case studies and discuss ethical questions such as:
- How can novel therapies be integrated with evidence-based proven therapies?
- How should clinicians respond to privately funded experimental treatments?
- What information should be given to patients about their efficacy?
- Under what circumstances is it ethically permissible to offer experimental treatments?
Professor Clare Delany, Professor of Ethics, The University of Melbourne
- Ben Dixon, Director, Head and Neck Department, St Vincent's Hospital Melbourne
- Morikatsu Wada, Radiation Oncologist, Austin Health
- Hui Gan, Clinical Research Lead, Austin Health
- Felicity Megee, Senior Speech Pathologist, Melbourne Health
- Carly Fox, Consultant Plastic Surgeon, Peter MacCallum Cancer Centre
- Lora Winter, Consumer Representative
- Rebecca Barnett, Head and Neck Nurse Coordinator, St Vincent’s Hospital Melbourne
Tuesday 19 October